Richard W. Paul & Associates, LLC Abbott Laboratories Transaction History

Richard W. Paul & Associates, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$95.53 - $114.62 $11,941 - $14,327	-125 Reduced 66.49%	63 $6.1 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $201 - $224	-2 Reduced 1.05%	188 $20.5 Million
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $278,472 - $327,778	-2,875 Reduced 93.8%	190 $19.2 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $291,358 - $341,808	3,065 New	3,065 $337 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Richard W. Paul & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Richard W. Paul & Associates, LLC with notifications on news.